Skip to search.
 BSE Up 0.51% NSE Up 0.56%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
52.26 Down 0.79(1.49%) 7:40pm - Nasdaq Real Time Price
Add to Portfolio
Prev Close:53.05
Open:52.72
Bid:51.69 x 200
Ask:51.80 x 300
1y Target Est:68.78
Beta:2.27
Next Earnings Date: 4-Aug-15ISIS Earnings announcement
Day's Range:51.60 - 52.80
52wk Range:29.17 - 77.80
Volume:240,986
Avg Vol (3m):2,369,060
Market Cap:6.26B
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.49%6.26B
ENZ 0.00%139.10M
GILDDown 0.54%169.14B
SRPTDown 0.38%1.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Jun-15) :0.29
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-7.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback